(PharmaNewsWire.Com, October 31, 2017 ) Sepsis is a three-staged syndrome; it starts with systemic infections leading to severe sepsis and ultimately causing sepsis shock, which is regarded as a medical emergency. Population with weak immune system, which include children, older adults, and people with chronic diseases such as cancer, AIDS, diabetes, are prone to sepsis.
Sepsis occurs mainly due to bacterial, viral, and fungal infections. Gram-negative bacilli such as E. coli, P. aeruginosa, E. corrodens, and Haemophilus influenzae (which occurs mainly in neonates) are the main agents that cause infection, leading to sepsis. Other bacteria which causes sepsis are S. aureus, Streptococcus species, Enterococcus species, and Neisseria species.
The report covers the present scenario and the growth prospects of the global sepsis diagnostics market for 2017-2021. To calculate the market size, the report considers the sales, volume and value of global sepsis diagnostics segment.
The market is divided into the following segments based on geography:
Americas APAC EMEA Key vendors
bioMérieux T2 Biosystems
Research report, Global Sepsis Diagnostics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Other prominent vendors
Alere Abionic AdvanDx Aethlon Medical AusDiagnostics Beckman Coulter Beckton Dickinson Momentum Bioscience Bio-Rad Laboratories Bruker Cepheid Curetis CytoSorbents Fast Track Diagnostics Hoffmann-La Roche Fujirebio Europe Hansa Medical Hain Lifescience Immunexpress Inflammatix Merck miacom diagnostics Mitsubishi Chemical Europe Nan?mix QIAGEN Radiometer Response Biomedical Sepset Biosciences Siemens Healthineers TCS Biosciences Thermo Fisher Scientific Market driver
Rising prevalence of hospital acquired infection (HAIs) globally For a full, detailed list, view our report Market challenge
High cost of sepsis treatment For a full, detailed list, view our report Market trend
Increasing use of biomarkers for sepsis For a full, detailed list, view our report Key questions answered in this report
What will the market size be in 2021 and what will the growth rate be? What are the key market trends? What is driving this market? What are the challenges to market growth? Who are the key vendors in this market space? You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Companies Mentioned:
bioMérieux, T2 Biosystems, Alere, Abionic, AdvanDx, Aethlon Medical, AusDiagnostics, Beckman Coulter, Beckton Dickinson, Momentum Bioscience, Bio-Rad Laboratories, Bruker, Cepheid, Curetis, CytoSorbents, Fast Track Diagnostics, F. Hoffmann-La Roche, Fujirebio Europe, Hansa Medical, Hain Lifescience, Immunexpress, Inflammatix, Merck, miacom diagnostics, Mitsubishi Chemical Europe, Nan?mix, QIAGEN, Radiometer, Response Biomedical, Sepset Biosciences, Siemens Healthineers, TCS Biosciences, and Thermo Fisher Scientific.
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
